Sort
10,766 grants matching “checkpoint inhibitor”
Investigating the Role of DNA Repair Mutations in Prostate Cancer Initiation, Progression, and Susceptibility to Targeted Therapies
$70,910Sander Barkley Frank · Fred Hutchinson Cancer Research Center · F32 · FY2020 · CA
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
$70,904Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · U54 · FY2023 · CA
Cancer Therapeutics
$70,697Eric R Prossnitz · University Of New Mexico Health Scis Ctr · P30 · FY2023 · CA
Cancer Therapeutics
$70,695Eric R Prossnitz · University Of New Mexico Health Scis Ctr · P30 · FY2024 · CA
Cancer Therapeutics
$70,695Eric R Prossnitz · University Of New Mexico Health Scis Ctr · P30 · FY2025 · CA
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors
$70,627David B Shackelford · University Of California Los Angeles · R01 · FY2024 · CA
Cancer Therapeutics
$70,510Eric R Prossnitz · University Of New Mexico Health Scis Ctr · P30 · FY2022 · CA
Imaging tumor and T cell responses to metabolic and immune modulation therapy
$70,499Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Role of the Gut Microbiota in Regulating Responses to anti-PD-1 Cancer Immunotherapy
$70,458Joon Seok Park · Harvard Medical School · F32 · FY2021 · CA
Translation of a novel combination therapy approach for non-Hodgkin lymphoma
$70,432Shruthi Naik · Mayo Clinic Rochester · U01 · FY2024 · CA
Control of Microtubule and Genome Integrity by the OBSL1-CUL7-CUL9-p53 Pathway
$70,268Yue Xiong · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
Identifying the role of Ntrk1 in immunosuppression in Kras/p53 mutant lung cancer
$70,146Jessica Konen · University Of Tx Md Anderson Can Ctr · F32 · FY2020 · CA
Clinical Investigations and Precision Therapeutics
$70,137Shridar Ganesan · Rutgers Biomedical And Health Sciences · P30 · FY2023 · CA
Tumor-derived Exosome Induction of Dendritic Cell Tolerization
$70,082Michael Paul Plebanek · Duke University · F32 · FY2022 · CA
Administrative-Core-001
$70,033Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2022 · CA
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
$70,033Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2022 · CA
Immuno/Oncology (IO)
$70,009Scott J Antonia · Duke University · P30 · FY2025 · CA
The Impact of ATR Kinase Inhibitors on CD8+ T Cell Expansion and Memory Development
$69,960Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Epigenetic therapy for pancreatic cancer
$69,950Gaoyang Liang · Salk Institute For Biological Studies · F32 · FY2019 · CA
Cancer Biology Program
$69,947Ann Marie Pendergast · Duke University · P30 · FY2021 · CA
Epigenetic regulators of subtype plasticity in bladder cancer
$69,802John Robert Christin · Columbia University Health Sciences · F32 · FY2022 · CA
Development of Novel Therapies for HIV Infection
$69,771Robert Yarchoan · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
The Role of NK Cells in Mediating the Immune Response in Irradiated HNSCC
$69,690Thomas E Bickett · University Of Colorado Denver · F32 · FY2021 · DE
Immune Checkpoint Regulation by the Integrated Stress Response Pathway in Lung Ca
$69,500Shayna Thomas-Jardin · Ut Southwestern Medical Center · F32 · FY2023 · CA
Studies of Materials with Physiological Properties
$69,426Harvard University · R01 · FY2005 · GM